VIMOVO

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Mevcut itibaren:

ASTRA ZENECA ISRAEL LTD

ATC kodu:

G02CC02

Farmasötik formu:

TABLETS MODIFIED RELEASE

Uygulama yolu:

PER OS

Tarafından üretildi:

ASTRA ZENECA AB., SWEDEN

Terapötik grubu:

NAPROXEN

Terapötik endikasyonlar:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Yetkilendirme tarihi:

2011-12-01